Wang J X, Mei L, Yamamura H I, Roeske W R
Department of Pharmacology, University of Arizona, Tucson.
J Pharmacol Exp Ther. 1987 Sep;242(3):981-90.
The binding properties of the putative M1 selective antagonist pirenzepine (PZ) to muscarinic acetylcholine receptor (mAChR) embedded in membranes and freed by solubilization with digitonin have been studied in the rat forebrain and heart. In the forebrain membranes, the k+1 and k-1 of [3H]PZ binding was 7.05 X 10(5) min-1 M-1 and 1.84 X 10(-3) min-1 (Kd = 3.34 nM), respectively, whereas those in heart membranes were estimated to be 1.21 X 10(5) min-1 M-1 and 7.46 X 10(-3) min-1 (Kd = 66 nM) by an indirect method. After solubilization, the kinetic parameters were determined as 3.17 X 10(5) min-1 M-1 and 2.23 X 10(-3) min-1 (Kd = 7.16 nM) in the forebrain and 2.41 X 10(5) min-1 M-1 and 1.41 X 10(-3) min-1 (Kd = 6.35 nM) in the heart. Similar dissociation constants were obtained from equilibrium saturation binding studies of [3H]PZ. Both high and low affinity binding sites for PZ were found in the forebrain membranes, whereas only one low affinity site was detected in the heart membranes. After solubilization, the inhibition curves in both tissues were better fitted to a one-site model with similar Ki values. The affinity of the agonist carbachol was decreased greatly in the heart and decreased slightly in the forebrain after solubilization to IC50 values that were similar in both tissues. Although 5'-guanylylimidodiphosphate was able to reduce the affinity of carbachol for membrane bound mAChR and to increase slightly the binding of (-)-[3H]quinuclidinyl benzilate it had no effect on ligand binding to the solubilized mAChR. The affinities of classic antagonists (-)-[3H]quinuclidinyl benzilate and atropine were not altered significantly by solubilization. Our results suggest that several different factors appear to be involved in the association and dissociation processes of PZ binding to the putative M1 (in forebrain) and M2 (in heart) mAChR in membranes. Most of these factors were separated from the receptors by solubilization under our conditions.
在大鼠前脑和心脏中,研究了推定的M1选择性拮抗剂哌仑西平(PZ)与通过用洋地黄皂苷溶解而从膜中释放出来的毒蕈碱型乙酰胆碱受体(mAChR)的结合特性。在前脑膜中,[3H]PZ结合的k+1和k-1分别为7.05×10(5) min-1 M-1和1.84×10(-3) min-1(Kd = 3.34 nM),而通过间接方法估计心脏膜中的k+1和k-1分别为1.21×10(5) min-1 M-1和7.46×10(-3) min-1(Kd = 66 nM)。溶解后,在前脑中测定的动力学参数为3.17×10(5) min-1 M-1和2.23×10(-3) min-1(Kd = 7.16 nM),在心脏中为2.41×10(5) min-1 M-1和1.41×10(-3) min-1(Kd = 6.35 nM)。从[3H]PZ的平衡饱和结合研究中获得了相似的解离常数。在前脑膜中发现了PZ的高亲和力和低亲和力结合位点,而在心脏膜中仅检测到一个低亲和力位点。溶解后,两个组织中的抑制曲线都更好地拟合到具有相似Ki值的单点模型。激动剂卡巴胆碱的亲和力在心脏中大大降低,在前脑中略有降低,溶解后IC50值在两个组织中相似。尽管5'-鸟苷酰亚胺二磷酸能够降低卡巴胆碱对膜结合mAChR的亲和力,并略微增加(-)-[3H]喹核醇基苯甲酸酯的结合,但它对配体与溶解的mAChR的结合没有影响。经典拮抗剂(-)-[3H]喹核醇基苯甲酸酯和阿托品的亲和力在溶解后没有明显改变。我们的结果表明,在膜中,几种不同的因素似乎参与了PZ与推定的M1(在前脑)和M2(在心脏)mAChR结合和解离的过程。在我们的条件下,通过溶解将这些因素中的大多数与受体分离。